Vincerx Pharma, Inc. - VINC

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2025 · Q4 2024
Value (USD)
Total reported value ($000)
$62K
QoQ value delta ($000)
-$493K (-88.83%)
Implied price effect (QoQ)
+92.46%
Shares
Total shares
124,403
QoQ shares delta
-2,018,860 (-94.2%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (VINC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2025)

Top 25 only Full list
Early Q2 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 22 42,777 0.0%
GOLDMAN SACHS GROUP INC 16 31,567 0.0%
GEODE CAPITAL MANAGEMENT, LLC 10 19,285 0.0%
VANGUARD GROUP INC 7 14,317 0.0%
MILLENNIUM MANAGEMENT LLC 5 10,798 0.0%
Tower Research Capital LLC (TRC) 1 2,997 0.0%
BlackRock, Inc. 1 2,352 0.0%
JPMORGAN CHASE & CO 0 1 0.0%
BANK OF AMERICA CORP /DE/ 0 15 0.0%
MORGAN STANLEY 0 102 0.0%
UBS Group AG 0 142 0.0%
SBI Securities Co., Ltd. 0 50 0.0%